newsfilter
← Latest News
GlobeNewswire·

resTORbio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

BOSTON, March 12, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or...